Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy.

Stamati MoriasLoredana G Marcu Michala ShortEileen GilesAndrew PotterJustin ShepherdThanh GierlachEva Bezak

Published in: Journal of oncology (2018)

Based on the studies reviewed SABR is a safe treatment technique for lung cancer; however, further well-designed phase III randomised clinical trials are required to produce timely conclusive results and to enable their comparison and statistical analysis.

Keyphrases

clinical trial
phase iii
radiation therapy
open label
end stage renal disease
double blind
newly diagnosed
chronic kidney disease
phase ii
randomized controlled trial
peritoneal dialysis
placebo controlled
combination therapy
radiation induced
patient reported outcomes
patient reported
smoking cessation